Contribution of high concentrations of PTH(1-34) to muscle weakness in uremia by suppression of guanidinoacetic acid synthesis.
Takeda
M
M
Kubota
M
M
Kiyatake
I
I
Tomino
Y
Y
Koide
H
H
D000818:Animals; D003401:Creatine / Q000172:deficiency; D005998:Glycine / Q000031:analogs & derivatives / Q000096:biosynthesis; D066298:In Vitro Techniques; D007684:Kidney Tubules / Q000187:drug effects / Q000378:metabolism; D009132:Muscles / Q000187:drug effects* / Q000503:physiopathology; D010281:Parathyroid Hormone / Q000008:administration & dosage / Q000633:toxicity*; D010446:Peptide Fragments / Q000008:administration & dosage / Q000633:toxicity*; D051381:Rats; D019379:Teriparatide; D014511:Uremia / Q000503:physiopathology*
D010281:Parathyroid Hormone; D010446:Peptide Fragments; D019379:Teriparatide; C004946:glycocyamine; D003401:Creatine; D005998:Glycine